Get started
Author

Tomás Cortadellas

Observed names: Cortadellas T, Cortadellas, Tomas, Cortadellas, Tomás, T Cortadellas, T. Cortadellas, T. Cortadellas Rosel, Tomas Cortadellas, Tomás Cortadellas Rosel
Observed institutions: Universitat Autònoma de Barcelona, Universitat Internacional de Catalunya, Hospital Universitario Dexeus, Vall d'Hebron Institut de Recerca, Hospital General de Catalunya, Vall d'Hebron Hospital Universitari
ORCID: 0000-0001-7225-7954
Observed ORCID: 0000-0001-7225-7954
OpenAlex ID: A5089730568
The superparamagnetic iron oxide is equivalent to the Tc99 radiotracer method for identifying the sentinel lymph node in breast cancer
2014 · I.T. Rubio, S. Diaz-Botero, et al. · European Journal of Surgical Oncology · 143
Estimation of tumor size in breast cancer comparing clinical examination, mammography, ultrasound and MRI—correlation with the pathological analysis of the surgical specimen
2017 · Tomas Cortadellas, Paula Argacha, et al. · Gland Surgery · 67
PDF
Electrothermal bipolar vessel sealing system in axillary dissection: A prospective randomized clinical study
2011 · Tomás Cortadellas, Octavi Córdoba, et al. · International Journal of Surgery · 43
PDF
Extensive nodal involvement increases the positivity of blue nodes in the axillary reverse mapping procedure in patients with breast cancer
2012 · Isabel T. Rubio, Isaac Cebrecos, et al. · Journal of Surgical Oncology · 33
Breast conservative surgery after neoadjuvant chemotherapy in breast cancer patients: Comparison of two tumor localization methods
2011 · M. Espinosa-Bravo, A. Sao Avilés, et al. · European Journal of Surgical Oncology · 32
Surgery improves survival in elderly with breast cancer. A study of 465 patients in a single institution
2015 · T. Cortadellas, O. Córdoba, et al. · European Journal of Surgical Oncology · 29
Detection of sentinel lymph node in breast cancer recurrence may change adjuvant treatment decision in patients with breast cancer recurrence and previous axillary surgery
2014 · Octavi Cordoba, Francesc Perez-Ceresuela, et al. · The Breast · 15
PDF
Surgery improves breast cancer-specific survival in octogenarians with early-stage breast cancer
2013 · Tomás Cortadellas, Andrea Gascón, et al. · International Journal of Surgery · 14
PDF
Elacestrant in Women with Estrogen Receptor–Positive and HER2-Negative Early Breast Cancer: Results from the Preoperative Window-of-Opportunity ELIPSE Trial
2025 · Maria Vidal, Claudette Falato, et al. · Clinical Cancer Research · 12
PDF
Abstract PD13-01: PD13-01 Elacestrant in postmenopausal women with estrogen receptor positive and HER2-negative early breast cancer: primary efficacy and safety analysis of the preoperative, window of opportunity SOLTI-1905-ELIPSE trial
2023 · Maria Vidal, Tomás Pascual, et al. · Cancer Research · 12
Removal of all radioactive sentinel nodes in breast cancer improves the detection of positive sentinel nodes
2008 · Isabel Rubio, Felisardo Pedreira, et al. · Clinical & Translational Oncology · 4
Abstract PD10-01: Elacestrant alone or in combination with triptorelin in premenopausal women with ER+/HER2- early breast cancer: primary analysis from the phase 2 SOLTI-2104- PremiÈRe trial
2026 · M. Bellet, P. Tolosa, et al. · Clinical Cancer Research · 2
When Is Sentinel Node Biopsy Indicated in High-Risk Ductal Carcinoma in situ? Four Hundred Sixty-Eight Cases from Three Institutions
2021 · Tomás Cortadellas, Paula Argacha, et al. · Breast Care · 2
The Peony trial: adding evidence to pertuzumab use in non-metastatic breast cancer
2020 · Tomas Cortadellas, Xavier Gonzàlez-Farré · Gland Surgery · 2
PDF
Comparison of ultrasound guided surgery and radio-guided occult lesions localization (ROLL) for nonpalpable breast cancer excision
2023 · Paula Argacha, Tomás Cortadellas, et al. · Gland Surgery · 1
PDF
Systematic Review and Meta-analysis of the Efficacy of Simulation Training in Gynecologic Laparoscopy
2026 · Laura Vilar Planella, Ignacio Rodríguez García, et al. · Journal of Minimally Invasive Gynecology
Supplementary Table S2 from Elacestrant in Women with Estrogen Receptor–Positive and HER2-Negative Early Breast Cancer: Results from the Preoperative Window-of-Opportunity ELIPSE Trial
2025 · Maria Vidal, Claudette Falato, et al.
PDF
Supplementary Figure S3 from Elacestrant in Women with Estrogen Receptor–Positive and HER2-Negative Early Breast Cancer: Results from the Preoperative Window-of-Opportunity ELIPSE Trial
2025 · Maria Vidal, Claudette Falato, et al.
Supplementary Figure S4 from Elacestrant in Women with Estrogen Receptor–Positive and HER2-Negative Early Breast Cancer: Results from the Preoperative Window-of-Opportunity ELIPSE Trial
2025 · Maria Vidal, Claudette Falato, et al.
Supplementary Table S3 from Elacestrant in Women with Estrogen Receptor–Positive and HER2-Negative Early Breast Cancer: Results from the Preoperative Window-of-Opportunity ELIPSE Trial
2025 · Maria Vidal, Claudette Falato, et al.
Supplementary Figure S1 from Elacestrant in Women with Estrogen Receptor–Positive and HER2-Negative Early Breast Cancer: Results from the Preoperative Window-of-Opportunity ELIPSE Trial
2025 · Maria Vidal, Claudette Falato, et al.
Supplementary Figure S2 from Elacestrant in Women with Estrogen Receptor–Positive and HER2-Negative Early Breast Cancer: Results from the Preoperative Window-of-Opportunity ELIPSE Trial
2025 · Maria Vidal, Claudette Falato, et al.
Data from Elacestrant in Women with Estrogen Receptor–Positive and HER2-Negative Early Breast Cancer: Results from the Preoperative Window-of-Opportunity ELIPSE Trial
2025 · Maria Vidal, Claudette Falato, et al.
Supplementary Table S4 from Elacestrant in Women with Estrogen Receptor–Positive and HER2-Negative Early Breast Cancer: Results from the Preoperative Window-of-Opportunity ELIPSE Trial
2025 · Maria Vidal, Claudette Falato, et al.
PDF
Supplementary Table S1 from Elacestrant in Women with Estrogen Receptor–Positive and HER2-Negative Early Breast Cancer: Results from the Preoperative Window-of-Opportunity ELIPSE Trial
2025 · Maria Vidal, Claudette Falato, et al.
Works count: 37
Citation count: 411
H-index: 10
I10-index: 10
Year
Topic
Type